We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRY
2126
DELISTED
Berry Corp
BRY
| $902K | ﹤0.01% |
95,666
+948
| +1% | +$8.86K |
|
|
TELL
2127
DELISTED
Tellurian Inc.
TELL
| $902K | ﹤0.01% |
123,877
+699
| +0.6% | +$5.32K |
|
2128
America's Car Mart
CRMT
$28.4M
| $901K | ﹤0.01% |
8,212
+22
| +0.3% | +$2.13K |
|
2129
Barrett Business Services
BBSI
$985M
| $899K | ﹤0.01% |
39,740
+232
| +0.6% | +$5.14K |
|
|
EB
2130
DELISTED
Eventbrite
EB
| $899K | ﹤0.01% |
44,590
+3,843
| +9% | +$73.5K |
|
2131
Schneider National
SNDR
$6.4B
| $899K | ﹤0.01% |
41,181
+26
| +0.1% | +$585 |
|
2132
Vera Bradley
VRA
$99.2M
| $898K | ﹤0.01% |
76,081
+4,774
| +7% | +$52.9K |
|
|
SHYF
2133
DELISTED
The Shyft Group
SHYF
| $897K | ﹤0.01% |
49,627
+547
| +1% | +$9.13K |
|
2134
Gossamer Bio
GOSS
$86.9M
| $895K | ﹤0.01% |
57,279
+2,266
| +4% | +$45.6K |
|
|
GHL
2135
DELISTED
Greenhill & Co., Inc.
GHL
| $894K | ﹤0.01% |
52,371
-428
| -0.8% | -$6.95K |
|
|
UCFC
2136
DELISTED
United Community Financial Corp
UCFC
| $892K | ﹤0.01% |
76,489
+499
| +0.7% | +$5.57K |
|
2137
Teekay Tankers
TNK
$2.58B
| $890K | ﹤0.01% |
37,149
+41
| +0.1% | +$746 |
|
2138
Astronics
ATRO
$3.81B
| $888K | ﹤0.01% |
38,114
+122
| +0.3% | +$3K |
|
2139
NextCure
NXTC
$21.4M
| $884K | ﹤0.01% |
+1,308
| New | +$656K |
|
|
DERM
2140
DELISTED
Dermira, Inc.
DERM
| $883K | ﹤0.01% |
58,251
+1,342
| +2% | +$11.6K |
|
2141
American Coastal Insurance
ACIC
$531M
| $881K | ﹤0.01% |
69,886
+2,875
| +4% | +$36.5K |
|
|
FBM
2142
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $878K | ﹤0.01% |
45,398
+23,351
| +106% | +$448K |
|
2143
York Water
YORW
$500M
| $876K | ﹤0.01% |
18,993
+27
| +0.1% | +$1.18K |
|
2144
Mercer International
MERC
$47.5M
| $875K | ﹤0.01% |
71,164
+2,371
| +3% | +$28.9K |
|
2145
Argan
AGX
$8.44B
| $873K | ﹤0.01% |
21,741
+118
| +0.5% | +$4.54K |
|
2146
W&T Offshore
WTI
$484M
| $864K | ﹤0.01% |
155,438
+3,858
| +3% | +$17.2K |
|
|
VRTV
2147
DELISTED
VERITIV CORPORATION
VRTV
| $863K | ﹤0.01% |
43,867
+2,061
| +5% | +$36K |
|
|
THOR
2148
DELISTED
Synthorx, Inc. Common Stock
THOR
| $861K | ﹤0.01% |
12,315
+1,613
| +15% | +$46.1K |
|
2149
Financial Institutions
FISI
$837M
| $858K | ﹤0.01% |
26,737
+82
| +0.3% | +$2.58K |
|
2150
Opko Health
OPK
$1.01B
| $855K | ﹤0.01% |
581,494
+30,997
| +6% | +$51.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.